Trial intelligence / Profile preview

Allogeneic stem cell transplantation with 3-day busulfan plus fludarabine conditioning in relapsed or refractory T- and NK/T-cell lymphomas

KCT0004030Phase 2Recruiting

Sponsor

Korea Otsuka Pharmaceutical

Start

Dec 2016

Modality

Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1